Two groundbreaking cell-based gene therapies, exagamglogene autotemcel and lovotibeglogene autotemcel, were recently approved by the FDA for the treatment of sickle cell disease.
Krystle Imamura, PharmD Candidate
Advertisement
Articles by Krystle Imamura, PharmD Candidate
Advertisement
Latest Updated Articles
Advances in Sickle Cell Disease: New Gene Therapies and Management StrategiesPublished: September 16th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
2
A Multifaceted Approach to Navigating Career Transitions in Pharmacy
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5
